Company profile
ETON PHARMACEUTICALS, INC.
NASDAQ:ETONBiotechnology: Pharmaceutical Preparations
Drug pipeline (8)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| ALKINDI SPRINKLE | approved | — | 4 | approved |
| BETAINE | approved | — | 0 | — |
| DESMODA | approved | — | 0 | — |
| GALZIN | approved | — | 0 | — |
| HEMANGEOL | approved | — | 0 | — |
Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.
Clinical trials (0)
No records yet.
FDA applications (8)
| Application | Approved | Type | Applicant | Products | ||||
|---|---|---|---|---|---|---|---|---|
| NDA 219873 | 2026-02-25 | NDA | ETON PHARMACEUTICALS INC | |||||
Loading… | ||||||||
| NDA 218980 | 2025-05-28 | NDA | ETON PHARMACEUTICALS INC | |||||
Loading… | ||||||||
| ANDA 216201 | 2023-05-25 | ANDA | ETON PHARMACEUTICALS INC | |||||
Loading… | ||||||||
| ANDA 210508 | 2022-01-28 | ANDA | ETON PHARMACEUTICALS INC | |||||
Loading… | ||||||||
| NDA 213876 | 2020-09-29 | NDA | ETON PHARMACEUTICALS INC | |||||
Loading… | ||||||||